Group 1: To prospectively determine the effect of PVB on perioperative pain and postoperative recovery following breast reduction. We will use patient-reported pain assessments (including a numeric rating scale) to evaluate our primary endpoint (pain scores on postoperative day 1 (POD1)) as well as additional outcome measures of pain scores in recovery and at 1 week post-surgery. To determine the effect of PVB on secondary endpoints of this study, we will calculate analgesic and antiemetic medication use, compare average time (minutes) spent in the PACU, average time (minutes) spent in Phase 2, total time (minutes) between the end of the operation and discharge to home, and evaluate the occurrence of unplanned hospital admission, PONV, overall satisfaction, patients' assessment of quality of recovery as determined by a validated survey [Gornall, Myles], and complications. This data will be obtained through review of medical records, surveys, and postoperative diaries.